Your trusted destination for CME, CPD & Medical Education across the Middle East.
University of Calgary / OncoHelix & Health-Tech Clinical Advisory, Calgary, Canada
Dr. Rehan Mujeeb Faridi is a high-complexity clinical laboratory director and molecular geneticist specializing in reproductive genomics, immunogenetics, and clinical variant interpretation. He holds a PhD in Human Genetics/Immunogenetics and is certified as a High-Complexity Clinical Laboratory Director (HCLD) by the American Board of Bioanalysis (ABB).
Dr. Faridi’s academic and clinical career spans pivotal roles at the University of Calgary's Department of Pathology and Laboratory Medicine, as well as directing high-complexity molecular diagnostic programs. His scientific work focuses heavily on reproductive immunology and genetics, including natural killer (NK) cell alloreactivity, HLA-G expression, trophoblast biology, and maternal-fetal genetic interactions in recurrent pregnancy loss and implantation failure.
With over 23 peer-reviewed publications in major international journals, Dr. Faridi has made landmark contributions to understanding the genetic architecture of unexplained pregnancy loss, cytokine gene variants, and advanced NGS-based non-invasive prenatal screening frameworks. He also consults on international laboratory accreditation standards (CAP, ISO-15189) and digital health tools for clinical genomics laboratories.
As a featured faculty speaker at the 2nd Trust Fertility & Gynecology Conference 2026, Dr. Faridi shares state-of-the-art insights on translational genomics in reproductive medicine. His lectures deliver practical guidance on integrating molecular diagnostics, evaluating mosaicism in embryo screening, and leveraging immunogenetic profiling to improve outcomes for patients with recurrent pregnancy loss and IVF failure.
